Literature DB >> 340325

Cimetidine in the treatment of duodenal ulcer: a multicenter double blind study.

H J Binder, A Cocco, R J Crossley, W Finkelstein, R Font, G Friedman, J Groarke, W Hughes, A F Johnson, J E McGuigan, R Summers, R Vlahcevic, E C Wilson, D H Winship.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 340325

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  36 in total

1.  Rebound intragastric hyperacidity after abrupt withdrawal of histamine H2 receptor blockade.

Authors:  C U Nwokolo; J T Smith; A M Sawyerr; R E Pounder
Journal:  Gut       Date:  1991-12       Impact factor: 23.059

2.  Rebound nocturnal hypersecretion after four weeks treatment with an H2 receptor antagonist.

Authors:  G M Fullarton; G McLauchlan; A Macdonald; G P Crean; K E McColl
Journal:  Gut       Date:  1989-04       Impact factor: 23.059

3.  Gastric acid secretion stimulated by modified sham-feeding, and the effects of histamine H2-antagonist and anti-muscarinic agent in patients with duodenal ulcer.

Authors:  S Ooi; E Kaneko
Journal:  Gastroenterol Jpn       Date:  1989-10

4.  Cimetidine or propantheline combined with antacid therapy for short-term treatment of duodenal ulcer.

Authors:  H O Adami; O Björklund; L K Enander; S Gustavsson; L Lööf; A Nordahl; A Rosén
Journal:  Dig Dis Sci       Date:  1982-05       Impact factor: 3.199

5.  Duodenal ulcer healing by separate reduction of postprandial and nocturnal acid secretions have different pathophysiology.

Authors:  S K Lam; C L Lai; M Ng; K H Fok; W M Hui
Journal:  Gut       Date:  1985-10       Impact factor: 23.059

6.  Is there a place in the United Kingdom for intensive antacid treatment for chronic peptic ulceration?

Authors:  R Faizallah; H A De Haan; N Krasner; R J Walker; A I Morris; M J Calam; D A Budgett
Journal:  Br Med J (Clin Res Ed)       Date:  1984-10-06

7.  Effect of 11R, 16, 16-trimethyl prostaglandin E2 on meal-stimulated gastric acid secretion in duodenal ulcer subjects.

Authors:  H J Lenz; S Brozinsky; M A Koss; D L Hogan; M L Scheinbaum; J I Isenberg
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

8.  Comparison of twice-daily ranitidine with standard cimetidine treatment of duodenal ulcer.

Authors:  R P Walt; I F Trotman; R Frost; P L Golding; T H Shepherd; J Rawlings; R H Hunt; D Colin-Jones; G J Milton-Thompson; J J Misiewicz
Journal:  Gut       Date:  1981-04       Impact factor: 23.059

9.  Tiotidine, a new H2-receptor antagonist, is a potent inhibitor of nocturnal acid secretion in duodenal ulcer patients.

Authors:  J E Valenzuela; R B Strecker; A P Douglas
Journal:  Dig Dis Sci       Date:  1981-05       Impact factor: 3.199

10.  [Histological and ultrastructural findings in the healing phase of duodenal ulcer].

Authors:  P Malfertheiner; G Bode; U Mader; K Baczako; A Stanescu; H Ditschuneit
Journal:  Klin Wochenschr       Date:  1985-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.